The Role of Lutein, Zeaxanthin, and Fish Oil on Cognitive Function and Bone Health in Healthy Adults

Status: Recruiting
Location: See location...
Intervention Type: Dietary supplement
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this clinical trial is to learn the impact of lutein, zeaxanthin, and fish oil (LZF) supplementation in healthy adults. The main question it aims to answer is: Will supplementation with LZF improve macular pigment optical density (MPOD), cognitive performance and bone mass compared to controls after six months? Subjects with an MPOD \<.43 will significantly improve MPOD after 6-months of LZF supplementation. Consuming a LZFO supplement for 6-months will improve visual cognitive performance. Consuming a LZFO supplement for 6-months will improve bone density. Participants will be asked to take either a LZF supplement or placebo daily for 6 months.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 45
Healthy Volunteers: t
View:

• \<.43 MPOD, a self-reported best-corrected vision of 20/40 or better in each eye, a BMI range of 18.5-30, and meets the inclusion criteria on the preliminary participant questionnaire.

Locations
United States
Texas
Gilchrist Building
RECRUITING
College Station
Contact Information
Primary
Karen M Beathard, PhD
karen-beathard@tamu.edu
979-220-2281
Backup
Steven E Riechman, PhD
sriechman@tamu.edu
979-862-3213
Time Frame
Start Date: 2024-02-07
Estimated Completion Date: 2026-05-01
Participants
Target number of participants: 80
Treatments
Active_comparator: LZF Supplement
Participants will take one LZF supplement daily for six months.
Placebo_comparator: Placebo
Participants will take on placebo supplement daily for six months.
Sponsors
Leads: Texas A&M University
Collaborators: Allen Foundation Inc.

This content was sourced from clinicaltrials.gov